WYC-210, a Tazarotene derivative, is a retinoid compound with lower anticancer activity[1]. WYC-210 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
[1] Cao, Xin, et al. Preparation of the retinoid compound and their application as anticancer agents. WO2017152725A1.
